Xiaoxiang Li

Title: Innovations and Contributions of Inventor Xiaoxiang Li

Introduction

Xiaoxiang Li is a notable inventor based in Anhui, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have important therapeutic applications. With a total of 4 patents to his name, his work has garnered attention for its potential impact on medical treatments.

Latest Patents

Among his latest patents is a "Guanidyl-containing P2Y12 receptor antagonist and preparation method and application thereof." This invention focuses on a P2Y12 receptor antagonist that contains a guanidyl group. The patent details a pyridazinone-guanidine compound, which exhibits multiple pharmacological activities, especially in inhibiting platelet aggregation. This compound can be utilized in preparing anti-platelet aggregation pharmaceutical compositions.

Another significant patent is related to an "intermediate used for preparing tapentadol or analogues thereof." This invention introduces a novel intermediate for the synthesis of tapentadol and its analogs, improving product yield and quality while reducing production costs. The environmentally friendly preparation process aligns with industrial production requirements.

Career Highlights

Xiaoxiang Li has worked with Anhui New Star Pharmaceutical Development Co., Ltd., where he has contributed to various innovative projects. His expertise in pharmaceutical development has been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Xiaoxiang Li has collaborated with notable colleagues, including Ziao Xu and Degang Li. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Xiaoxiang Li's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of pharmacology and a dedication to improving therapeutic options for patients.